NASDAQ:RXRX | Profit Breakdown | RECURSION PHARMACEUTICALS, INC.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$7.67M-$134.97M-$131.01M-$131.01M
2026-03-31$6.47M-$128.51M-$122.11M-$117.5M
2025-12-31$35.54M-$108.33M-$108.1M-$108.12M
2025-09-30$5.18M-$172.2M-$162.25M-$162.25M
2025-06-30$19.22M-$176.23M-$171.9M-$171.9M
2025-03-31$14.75M-$191.37M-$202.65M-$202.49M
2024-12-31$4.55M-$183.77M-$178.9M-$178.91M
2024-09-30$26.08M-$98.35M-$95.68M-$95.84M
2024-06-30$14.42M-$100.54M-$98.06M-$97.54M
2024-03-31$13.79M-$96.34M-$92.15M-$91.37M
2023-12-31$10.89M-$98.93M-$97.06M-$93M
2023-09-30$10.53M-$99.55M-$93.02M-$93.02M
2023-06-30$11.02M-$81.72M-$76.73M-$76.73M
2023-03-31$12.13M-$69.87M-$65.33M-$65.33M
2022-12-31$13.68M-$60.98M-$57.49M
2022-09-30$13.16M-$62.57M-$60.45M
2022-06-30$7.67M-$66.19M-$65.56M
2022-03-31$5.33M-$55.98M-$55.98M
2021-12-31$2.53M-$64.96M-$64.93M
2021-09-30$2.53M-$46.4M-$47.43M
2021-06-30$2.55M-$40.93M-$43.4M
2021-03-31$2.56M-$30.48M-$30.72M
2020-12-31$2.69M-$25.58M-$25.77M
2020-09-30$1.03M-$22.47M-$23.87M
2020-06-30$186,000.00-$18.22M-$18.94M
2020-03-31$60,000.00-$18.34M-$18.42M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$74.68M-$648.13M-$644.9M-$644.76M
2024-12-31$58.84M-$479M-$464.79M-$463.66M
2023-12-31$44.58M-$350.06M-$332.13M-$328.07M
2022-12-31$39.84M-$245.73M-$239.48M-$239.48M
2021-12-31$10.18M-$182.78M-$186.48M-$186.48M
2020-12-31$3.96M-$84.62M-$87.01M
2019-12-31$2.32M-$62.44M-$61.88M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.